Key Highlights: Implications: The deal adds ~$90–100 million of annualized revenue visibility from 2029, diversifies Gland’s customer base, and strengthens its credibility as a o...
Key Highlights: Implications: The new cGMP/US FDA/EU-compliant suite at Gland’s Visakhapatnam JNPC site, adding ~1,400 kg/year of sterile API capacity, should help both companies capture m...
Key Highlights: Implications: By adding the NSE to its existing BSE listing, Fermenta can attract more institutional and retail participation, which may support tighter spr...
Key Highlights: Implications: By consolidating three injectable-focused entities under one legal umbrella, Aurobindo can streamline manufacturing, R&D, and commercial operati...
Key Highlights: Implications: The expansion makes Turbhe more competitive for high-potency peptides, HPAPIs, and biomolecules, helping Piramal attract programs that need safe, sm...
Key Highlights: Implications: If completed, the transaction would likely be a strong validation event for mid-sized Indian pharmaceutical businesses that combine branded generics, nu...
Key Highlights: Implications: The launch positions Eisai to capture first-mover advantage in India’s underpenetrated dementia market, where prevalence is already large and expected t...
Key Highlights: Implications: The ₹230 crore Series A gives Arboreal the capital to scale its ingredient technology platform, expand manufacturing and accelerate R&D and commercialisat...
Key Highlights: Implications: The collaboration gives Arica Pharmaceutical a potential growth catalyst as it moves beyond its core anti-diabetic, neurosciences, and cardiovascular portfolio...
Key Highlights: Implications:The restructuring positions RPG Life Sciences to build a more focused and scalable API platform by separating the business from its formulations operations and backing it ...
